Ludwig Suter

1.4k total citations
25 papers, 852 citations indexed

About

Ludwig Suter is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ludwig Suter has authored 25 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ludwig Suter's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Immunotherapy and Immune Responses (8 papers) and Cutaneous Melanoma Detection and Management (8 papers). Ludwig Suter is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Immunotherapy and Immune Responses (8 papers) and Cutaneous Melanoma Detection and Management (8 papers). Ludwig Suter collaborates with scholars based in Germany, United States and Netherlands. Ludwig Suter's co-authors include Clemens Sorg, Eva‐Bettina Bröcker, Josef Brüggen, E. Macher, Andrea Lippold, Dirk J. Ruiter, Friedrich Otto, Beate M. Czarnetzki, Dirk Schadendorf and Johannes Schumann and has published in prestigious journals such as The Journal of Immunology, Cancer and Cancer Research.

In The Last Decade

Ludwig Suter

23 papers receiving 806 citations

Peers

Countries citing papers authored by Ludwig Suter

Since Specialization

Citations

This map shows the geographic impact of Ludwig Suter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludwig Suter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludwig Suter more than expected).

Fields of papers citing papers by Ludwig Suter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludwig Suter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludwig Suter. The network helps show where Ludwig Suter may publish in the future.

Co-authorship network of co-authors of Ludwig Suter

This figure shows the co-authorship network connecting the top 25 collaborators of Ludwig Suter. A scholar is included among the top collaborators of Ludwig Suter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludwig Suter. Ludwig Suter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging 2018 ·JNCI Cancer Spectrum ·Georg Brunner, Achim Heinecke, Thomas Falk, (unknown), Norbert Blödorn‐Schlicht, Hans‐Joachim Schulze, Ludwig Suter, Jens Atzpodien, Carola Berking	24
2	Abstract 2861: Independent validation of a prognostic gene-signature based risk score in formalin-fixed paraffin-embedded melanomas 2014 ·Cancer Research ·Georg Brunner, Achim Heinecke, Ludwig Suter, Norbert Blödorn‐Schlicht, Hans‐Joachim Schulze, Jens Atzpodien	0
3	Increased Expression of the Tumor Suppressor PLZF Is a Continuous Predictor of Long-Term Survival in Malignant Melanoma Patients 2008 ·Cancer Biotherapy and Radiopharmaceuticals ·Georg Brunner, Martina Reitz, V. Schwipper, (unknown), Andrea Lippold, (unknown), Ludwig Suter, Jens Atzpodien	30
4	Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas 2005 ·Journal of the American Academy of Dermatology ·K.W. Schulte, Andrea Lippold, (unknown), (unknown), Claudia Breitkopf, (unknown), (unknown), (unknown), (unknown), Rainer Rupprecht, Ludwig Suter	65
5	The prognostic value of the expression of collagenase IV, cathepsin D and metallothionein in squamous cell carcinomas of the skin determined by immunohistochemistry 2001 ·Archives of Dermatological Research ·Torsten Goldmann, (unknown), Klaus Hermann Wiedorn, Ludwig Suter, Friedrich Otto	8
6	The Expression of Proteolytic Enzymes at the Dermal Invading Front of Primary Cutaneous Melanoma Predicts Metastasis 1999 ·Pathology - Research and Practice ·Torsten Goldmann, Ludwig Suter, Dietrich Ribbert, Friedrich Otto	19
7	Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma? 1999 ·Cancer ·(unknown), (unknown), Friedrich Otto, (unknown), Andrea Lippold, Volker Krieg, Ludwig Suter	67
8	Prognostic Classification of Malignant Melanomas by Combining Clinical, Histological, and Immunohistochemical Parameters 1999 ·Oncology ·(unknown), Torsten Goldmann, (unknown), Andrea Lippold, Ludwig Suter, Ulrike Westhoff	25
9	Ungew�hnliche Strahlenreaktion nach R�ntgenweichstrahltherapie bei einer Patientin mit Pemphigus vulgaris 1995 ·Der Hautarzt ·Claudia Breitkopf, Ludwig Suter	2
10	Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours 1993 ·The Journal of Pathology ·Dirk Schadendorf, (unknown), (unknown), (unknown), Ludwig Suter, Beate M. Czarnetzki	87
11	p-Glycoprotein expression in malignant melanoma 1991 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), Ludwig Suter	19
12	Metastatic human melanoma 1989 ·Journal of Cancer Research and Clinical Oncology ·Ludwig Suter, (unknown), (unknown), Johannes Schumann, Clemens Sorg	6
13	Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype 1987 ·Cancer Immunology Immunotherapy ·(unknown), G. Zwadlo, Ludwig Suter, Martin Brüne, Clemens Sorg	39
14	Phenotypic dynamics of tumor progression in human malignant melanoma 1985 ·International Journal of Cancer ·Eva‐Bettina Bröcker, Ludwig Suter, Josef Brüggen, Dirk J. Ruiter, E. Macher, Clemens Sorg	137
15	DNA Aneuploidy in Congenital Melanocytic Nevi: Suggestive Evidence for Premalignant Changes 1984 ·Journal of Investigative Dermatology ·W. Stenzinger, Ludwig Suter, Johannes Schumann	42
16	HLA-DR Antigen Expression in Primary Melanomas of the Skin 1984 ·Journal of Investigative Dermatology ·Eva‐Bettina Bröcker, Ludwig Suter, Clemens Sorg	116
17	Monoclonal gammopathies in sézary syndrome: A report of four new cases and a review of the literature 1981 ·Cancer ·(unknown), Ludwig Suter, E. Macher, H. R. Niedorf, Ekkehard Grundmann, (unknown), J. J. Herzberg, (unknown), (unknown), (unknown), H Lösse	24
18	Human Malignant Melanoma: Assay of Tumor Associated Antigens by Use of Rabbit Antisera 1980 ·Journal of Investigative Dermatology ·Ludwig Suter, Josef Brüggen, F Vakilzadeh, (unknown), E. Macher	1
19	Use of an enzyme-linked immunosorbent assay (ELISA) for screening of hybridoma antibodies against cell surface antigens 1980 ·Journal of Immunological Methods ·Ludwig Suter, Josef Brüggen, Clemens Sorg	73
20	Zur Strukturregel der Antikörper. Die Primärstruktur einer monoklonalen Immunglobulin-L-Kette vom ϰ-Typ, Subgruppe III (Bence-Jones-Protein Ti). I. Reinigung und Charakterisierung des Proteins 1972 ·Hoppe-Seyler´s Zeitschrift für physiologische Chemie ·Ludwig Suter, (unknown), N Hilschmann	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact